Remove 2002 Remove FDA Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells. United States Food and Drug Administration (FDA) – Regulations and guidance. The FDA is issuing this guidance to provide clarity and predictability for software manufacturers on this topic.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – May

SQA

Food and Drug Administration (FDA) and product manufacturers are aware that it may be present in food and drug products at trace levels, and those very low levels do not pose a safety concern for consumers. World Health Organization (WHO). of devices worldwide have experienced this problem. WHO Pharmaceuticals Newsletter, No.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

This edition is aligned with the latest regulatory guidelines, including EU Annex 1 (revised 2022), EU Annex 15, the FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practices, and the FDA Draft Guidance for Industry: Current Good Manufacturing Practice for Medical Gases.

FDA 52